Sundheds- og Ældreudvalget 2019-20
SUU Alm.del Bilag 355
Offentligt
2186289_0001.png
Studies and outcomes
October 1st, 2019
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0002.png
Diabetes can be
reversed
for 56% via lifestyle change (JAMA study)
•
A study published in August 2017 in the respected Journal of The
American Medical Association (JAMA) by Professor Bente Klarlund
Pedersen (and 14 others) from the University Hospital of
Copenhagen documented that type-2
diabetes can be rolled back
through lifestyle intervention: 56% can have the diagnosis reverted
altogether.
This intervention is based on six exercise sessions every week, and
dietary coaching.
56
%
of diabetics can be
reversed
80%
70%
•
17,10%
60%
Discontinue medication
50%
Reduce medication
40%
Professor Bente
Klarlund Pedersen
Copenhagen University
Hospital
30%
56,40%
11,70%
14,70%
20%
10%
0%
Lifestyle
intervention
Standard treatment
Authors: Mette Yun Johansen, MSc; Christopher Scott
MacDonald, MSc; Katrine Bagge Hansen, MD, PhD; Kristian
Karstoft, MD, PhD; Robin Christensen, PhD; Maria Pedersen,
MD, PhD; Louise Seier Hansen, MSc; Morten Zacho, MSc;
Anne-SophieWedell-Neergaard, MD; Signe Tellerup Nielsen,
MD, PhD; Ulrik Wining Iepsen, MD, PhD; Henning Langberg,
DMSc; Allan Arthur Vaag, DMSc;
Bente Klarlund Pedersen,
DMSc; Mathias Ried-Larsen, PhD
Source: JAMA. 2017;318(7):637-646.
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0003.png
Introduction to Liva Healthcare –
The
digital health coaching
Liva Healthcare is a multi-award winning European digital health coaching company.
It has head offices
in Copenhagen and London and operations in multiple countries across four continents (Europe, Asia,
Australia and North America).
•
•
•
Key competences:
Liva helps healthcare players to drive outcomes and adherence through digitally-
assisted lifestyle change as an integral part of clinical pathways.
Track record:
Liva was founded by the team behind NetDoctor.com, one of Europe’s largest
independent health information portals launched in 1998 (visit
NetDoktor.de
or
NetDoctor.co.uk)
Platform:
The first version of the digital coaching platform and service launched in 2002. Since then, it
has been continuously refined based on best practice and more than 150,000 patients have been
through programmes. The disease-agnostic platform is highly flexible and can adapt to programmes in
areas including rehabilitation, disease management, prevention, lifestyle change.
Coaching:
Liva also uses its platform to deliver personalised individual coaching and disease
management services – all based on proven behaviour change psychology models. Liva is unique in that
it uses real coaches, not avatars, for better relationship building throughout a programme.
Clinical outcomes:
Several studies show remarkable outcomes from Liva’s services: adherence rates
of 60-80% after six months; sustainable weight loss of 4-6% of body weight after 18 months; and a 35-
40% reversal rate of pre-diabetic and T2D patients by lowering their Hb1Ac.
Geographical reach:
Liva currently operates in The United Kingdom, Denmark, Sweden, Spain,
Singapore, and Canada and is onboarding new clients in Australia, Ireland, Netherlands, Norway,
Finland and Germany. As a general rule of thumb, we can be operational in a new country within 3-4
months.
Key clients:
Liva has been selected by some of Europe’s largest healthcare players including NHS
England, AXA PPP Healthcare, and a number of large international pharma and insurance companies.
3
•
•
•
•
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0004.png
The Liva tech platform includes five main
components
1
On-boarding site
– choose your personal health coach (if free choice of coach is selected
in the programme and service design phase)
2
User apps
– Apple and Android native user apps (can be white-labelled as an
option)
3
Coaching and user management platform
– up to 2-500 users can be managed per
coach (depending on chosen intervention intensity)
4
Data mining cockpit
– real world / real time population statistics
5
API for Integration to EHR systems
– Liva provides an API to integrate into Electronic
Health Record (EHR) systems (if relevant and systems are compatible; optional
implementation will be according to time and material by rate card).
4
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0005.png
App’en
– Liva set fra borgerens vinkel
Liva app’ens hovedfunktioner
Skræddersyet
livsstilsplan
Borger og vejleder
bygger i fælleskab en
skræddersyet plan ved
at aktivere/deaktivere
mål. Planen bygges med
fokus på borgers ønsker,
behov og formåen.
(Native app til både android og IOS)
Aftale
Borger og vejleder
udarbejder en
aftale. Der nemt
kan genses af
begge parter om
nødvendigt.
Idag siden
- Se vejleder
- Se aftale
- Dage til næste
vejledning
- Daglige registreringer
Daglige registreringer
Skridt og motion
–
Aktivitetsniveau
Kost
– inkl. Billeder
Levemål
– Lave 2 ansøgninger,
stå op før kl.9 osv.
Medicin
– Huske medicin indtag
Rygning
– Registrere det daglige
forbrug
Vægt, blodtryk og blodsukker
–
Vejlederen kan følge proccessen
- Og meget mere
Fremskridt
Borger kan følge sine
daglige/ ugentlige/ årlige
fremskridt, samt har
adgang til personlig
statistik på alle
livsstilsparametre.
Løbende dialog
Borger og vejleder
har løbende
asynkron dialog
via tekst og video.
Derudover kan
der sendes pdf’er,
links og billeder.
Grupper
Små grupper
indeholdende borgere
med samme udfordringer
eller fra samme område.
”rygere”, ” diabetikere”,
”bosat nær Odense”
Forum
Interagere med andre
borgere – dele erfaringer
og få motivation og
inspiration.
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0006.png
Vejlederplatform
– Liva set fra vejlederens vinkel
Liva fører kalender
Med Liva får du et hurtigt
overblik over alle
borgere, hvem der skal
vejledes i dag og et
overblik over processen
og hvorledes
målsætningerne
opfyldes.
Live videomøde
Vejleder kan oprette et
live videomøde med en
borger både ved opstart
eller for at skabe
yderligere engagement
Vejledning
Hovedfunktioner til administration af
borgere
Gruppebeskeder
Send gruppebeskeder
til hundredvis af
borgere på en gang
- Se, følg og ret i
målsætninger
- Se resultater og fremskridt
- Video og tekst beskeder
-
Journalnoter
-
Alt samlet på eet sted
Grupper
Dannelse af grupper fra
samme område eller med
samme udfordringer. Fx
rygestop eller behov for
social interaktion,
motivation og
uddannelse.
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0007.png
Overblik – det er nemt at få overblik over de
indtastede sundhedsdata
7
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0008.png
Data security and privacy: Liva is ISO27001
approved and audited by PWC
As a healthcare company that develops and operates healthcare solutions globally, Liva Healthcare takes security
and careful data handling extremely seriously. We are committed to complying with all applicable personal data
protection laws in our countries of operation, and have taken a number of important steps in that regard, as shown
below.
The Liva Healthcare data protection commitment is the basis for our global personal data protection compliance
programme, which also includes governance structure, procedures, trainings, and oversight mechanisms to ensure
effective data protection and respect for the rights of data subjects.
ISO/IEC 27001:2013 is the
international standard Liva
is complying to.
Our ongoing efforts in
remaining best-in-class is
continuously audited by
REVI-IT (a
Danish State
Authorised Audit firm
specialised in Information
security audits and
accreditations),
delivering
independent assessments
of our ISMS compliance.
Liva is in full compliance
with The General Data
Protection Regulation
(GDPR) (Regulation (EU)
2016/679) which is a
regulation intended to
strengthen and unify data
protection for all
individuals within the EU.
GDPR took effect 25 May
2018, and replaced the
data protection directive
(officially Directive
95/46/EC) of 1995.
Our commitment to
comply with personal data
laws and standards
includes compliance with
NHS England’s
Information Governance
Toolkit concerning patients
and service vendors under
the NHS. Among the
related laws are The Data
Protection Act, and the
Confidentiality NHS Code
of Practice.
Liva Healthcare operates
with the CE marking,
which is a certification
mark that concludes
conformity with health,
safety, and environmental
protection standards for
products sold within the
European Economic Area.
The CE marking is
recognizable worldwide
and a token of meeting the
requirements of the
applicable EC directives.
QIS2015 is the
“gold standard” for self-
management to assure
delivery of
consistently high quality.
8
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0009.png
Device integration for patient data gathering
Liva is fully integrated with both the Apple HealthKit and Google Fit standards, that will cover hundreds of mobile
healthcare tracking devices. In addition to the two main standards, Liva is fully integrated with all other major producers
of health tracking devices, such as Dexcom, Polar, Fitbit, Withings, iGLucose etc. This means that patients investing in
self-monitoring equipment will have all vitals transferred automatically via Bluetooth or Wi-Fi.
✅
✅
9
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0010.png
National Health Service UK
Digital Diabetes Prevention Programme
•
•
•
•
5.000 pre-diabetics and obese patients
Referred via own doctor in general practice
1 year of digital life-style intervention (Liva Full-Service)
Inclusion period: January 2018 - December 2019
NHS will enrol 200.000 patients a year (2019-2022) in their NHS
DPP program. 20% of these will be digital interventions and
Liva just got one of the five seats.
10
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0011.png
Pre-diabetic outcomes - Active participants
Clinical outcomes, a brief summary - Pre-diabetes real world data
Liva demonstrates marked weight loss and reversal of pre-diabetes in real world setting.
Pre-diabetic outcomes - Active on the serve for at least 11 months, and data in valid range (between 11 to 13 months)
NHS National Diabetes Prevention Programme, UK: 152 prediabetes patients with available 12 months measurements.
80%
reduced HbA1c
after 12 months
(n=122/152)
47%
reversed
after
12 months*
(n=68/144)
35%
Lost >5% of initial
bodyweight
(n=46/130)
.
* reversed: HbA1c < 42mmol/mol at 12 months when the HbA1c > 42mmol/mol at baseline
Confidential preliminary results from the National Diabetes Prevention Programme UK: 988 prediabetes and overweight patients referred from
general practice to 1-year digital lifestyle intervention (Liva full-service). Inclusion from Jan. 2018-December 2018.
11
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0012.png
Clinical outcomes, a brief summary (pre-diabetes and T2D, real world, real time data)
Liva demonstrates marked weight loss, reversal of pre-diabetes and reversal of
diabetes in real world settings:
Pre-diabetic outcomes:
•
•
65% of prediabetes patients’ HbA1c levels are reduced at six months – results which
are maintained at 12 months
40% of prediabetics are reverted to non-diabetic state at six months – results which are
maintained at 12 months
(Preliminary results – NHS National Diabetes Prevention programme, UK)[ref 1]
•
•
•
Diabetic patients (type 2)
34% are reverted to a non-diabetic state (HbA1c <48mmol/mol) compared to 14%
among controls after six months.
80% of obese patients lose weight - on avg. 5.8 kg ~5.7% of initial bodyweight among
intervention group compared to 46% who lose weight in control group – on avg. 3.0 kg
~ 3.1% of initial body weight after six months.
(Preliminary results Liva study in Denmark)[ref
2]
12
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0013.png
Clinical outcomes, a brief summary (T2D, ongoing RCT study)
•
•
•
•
•
Design:
Randomized controlled two arm trial implemented in the Region of Southern
Denmark.
Inclusion criteria:
Diabetes patients (Hba1c 47+ mmol/mol) and overweight/Obesity
(BMI>25). 170 in each arm with 100 in intervention and 70 in the control group. In total 340
patients. Inclusion from Jan 2018-March 2019.
Status:
Per October 1st, 2019: 340 patients are onboarded for intervention and control. Within
the intervention population 100% have been in intervention for 6+ months
Preliminary results:
Please note that these results are preliminary since the study is still
ongoing and hence results are strictly confidential.
Retention:
•
Retention rate at 3 months: 93%
•
Retention rate at 6 months: 85%
•
Retention rate at 9 months: 76%
Outcomes among overweight/obese patients at six months:
80% lose weight - on avg.
5.8 kg ~ 5.7% of initial bodyweight among intervention group compared to 46% who lose
weight in control group – on avg. 3.0 kg ~ 3.1% of initial body weight.
Outcomes among diabetes patients at six months:
34% are reverted to a prediabetic state
(HbA1c <48mmol/mol) compared to 14% among controls. 82% lose weight - on avg. 5.2 kg ~
5.1% of initial bodyweight among intervention group compared to 69% who lose weight in
control group – on avg. 2.8 kg ~ 2.6% of initial body weight.
13
•
•
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0014.png
Clinical outcomes, a brief summary (overweight and obese patients)
•
•
•
Avg. 6.3% bodyweight reduction (or 6.8 kg weight loss) among diabetes patients
after nine months intervention in a municipal real-life setting (Komkova 2019)
Liva is cost effective already after one year of implementation – seen in a
municipality perspective (ApEHR 2017) [Ref 3]
7 kg weight loss sustained at 20 months in Denmark (Brandt 2011)
Sources:
[Ref 1] Confidential preliminary results from the National Diabetes Prevention Programme
UK: 988 prediabetes and overweight patients referred from general practice to 1-year
digital lifestyle intervention (Liva full-service). Inclusion from Jan. 2018-December 2018.
[Ref 2] Confidential preliminary results from Liva Study DK: Randomized controlled trial
with 200 overweight and diabetes patients in a 1-year intervention, (Liva full-service).
Inclusion from Jan 2018-Jan 2019.
[Ref 3] Cost-effective analysis of implementation of Liva intervention from the perspective
of a Danish municipality as the payor of the service. Conducted by the independent
research organization Applied Economics and Health Research, (ApEHR). See full report
at
https://livahealthcare.com/wp-content/uploads/2018/11/Report_Apehr_2017.pdf
14
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0015.png
Internal Published Studies on Liva Platform and Intervention (1/4)
7.0 kg weight loss attained in 4 months and sustained after 20 months
Average Weight Loss (kg)
10
8
6
4
2
0
7,0
7,0
2011
1
4-Month
20-Month
Weight loss at 20 months
•
Average 7.0 kg weight loss attained after 4 months
•
This weight loss is further sustained throughout
follow-up to 20 months
Intervention
•
Combination of face-to-face coaching with online
coaching in a GP setting
•
Increased exercise and low calorie diet advice
Conclusion
•
Findings may indicate the efficacy of
intervention as a way to efficiently and cost-
effectively drive sustainable weight loss for a
large population
5.4 kg weight loss sustained after 12 months
Weight loss 12 months
(kg)
6
4
2
0
5,4
2,8
Weight loss at 12 months
•
Average 5.4 kg weight loss compared to 2.8 kg in
a control group receiving usual care
•
61% of patients remained engaged in the
program for the full 12 months
Intervention
•
Combination of in person coaching with online
coaching
•
Increased exercise and low calorie diet advice
within National Health Service (NHS) England
2017
2
Intervention
Control
1.
2.
Brandt et al., “Sustained Weight Loss during 20 Months using a Personalized Interactive Internet Based Dietician Advice Program in a General Practice Setting”,
International Journal on Advances in Life Sciences,
2011; 3
Haste et al., “Web-Based Weight Loss Intervention for Men with Type 2 Diabetes: Pilot Randomized Controlled Trial.”
JMIR,
2017; 2
15
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0016.png
Internal Published Studies on Liva Platform and Intervention (2/4)
A strong human relationship is the most important driver of long-term weight loss
Conclusions
•
This study found that the most important driver in
long-term weight loss was a strong relationship
between the patient and a healthcare professional
•
Continuous positive support was perceived as an
important factor for long-term success
•
Collaborative e-health tools are able to support
the relationship between patients and health
professionals, and drive behavioral changes
“A strong human
relationship is key in driving
long-term weight loss”
2018
1
General practitioners are willing to use eHealth more frequently for patients
“General practitioners are
willing to use eHealth more
frequently for patients –
however education is
needed”
2017
2
16
Conclusions
•
GPs are familiar with behavioral change
techniques and ready to use them in e-health for
patients whey can assist in optimising processes
and do not hinder other forms of treatment
•
Looking ahead, education of GPs and recognizing
patients’ ability and preference to use e-health
are needed
1.
2.
Brandt et al., “Drivers for successful long-term lifestyle change, the role of e-health: A Qualitative Study”,
BMJ Open,
2018; 8
Brandt et al., “General practitioners’ perspective on eHealth and lifestyle change: Qualitative Interview Study”,
JMIR mHealth and uHealth,
Vol 6, no 4, 2018
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0017.png
Internal Published Studies on Liva Platform and Intervention (3/4)
Predicting Dropouts from life style interventions: Analysis of Methods and Predictors
Societal cost savings of
Liva intervention
€25.000
Published
research
€ 19.918
€20.000
€15.000
€10.000
€5.000
€0
Before Liva
intervention
€ 17.778
2019
1
After Liva
intervention
Conclusions
•
Average 3.5% body weight reduction (3.9 kg)
among Type 2 diabetes patients on Liva
platform for 6 months (pilot data)
•
Prior research indicates that a 1% reduction in
body weight among diabetes patients
corresponds to 3.1% reduction in societal costs
•
Potential for societal cost savings of €2,140 per
patient per year
•
Liva’s intervention provides a cost-effective
solution for municipalities, saving money and
improving outcomes within a year of initiation
Is Lifestyle Coaching for diabetes patients cost effective in a municipal setting?
Effectiveness of eHealth Lifestyle Coaching among diabetes patients in a real life Municipality setting
Komkova et al. 2018 – Jmir Diabetes
Objective
•
Assess effectiveness of e-health lifestyle coaching among diabetes patients in a municipal setting
Methods
•
An observational study examining the effect of eHealth lifestyle coaching on self-reported weight change
among 103 obese diabetes patients, in programme for between 3 and 12 months, in a municipal setting.
Results
•
Significant weight reduction, on average 4.3% of the initial body mass, corresponding to 4.8 kg over mean
period of 7.3 months.
•
Annual saving of 2667€ per patient
•
Patients who had used the eHealth tool for over 9 months achieved a weight reduction of 6.3% or 6.8 kg.
1.
2.
Economic report performed by Applied Economics and Health Research, August 2017
JMIR Diabetes.
2019 Mar 12;4(1):e12140. doi: 10.2196/12140. Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study
17
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0018.png
Internal Published Studies on Liva Platform and Intervention (4/4)
Predicting Droputs from Life style interventions: Analysis of methods and predictors
Department for
Health Informatics
and Technology
“Data mining
methods can support
health coaches in
preventing drop-out
from digital
interventions”
This study aimed to gain insight into the causes of attrition for patients in an
electronic health intervention and evaluate if attrition can be predicted and
consequently prevented
Methods
Data from 2684 patients using an eHealth platform were iteratively analyzed
using logistic regression, decision trees, and random forest models.
Conclusions
Dropouts from eHealth lifestyle interventions can be predicted supporting
health coaches in preventing attrition by receiving proactive warnings. The
best performing predictive model was found to be the random forest
1.
Pedersen et al. Predicting Dropouts From an Electronic Health Platform for Lifestyle Interventions: Analysis of Methods and Predictors. Journal of medical internet research. 2019. Vol 21. iss. 9
18
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0019.png
Scientific Research Studies on Liva Underway (1/4)
What is the effect of eHealth intervention among chronic heart disease patients?
Effectiveness of a complex interactive eHealth intervention (Liva) on patient-reported and clinical
outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD Trial]: Study
Protocol of a National Danish Randomized Controlled Trial
Pedersen et al. 2018. In writing for publication. Study in progress
Objective
•
To evaluate the effectiveness of the ACQUIRE-ICD care innovation, a comprehensive and interactive e-
health intervention, on patient-reported and clinical outcomes
Methods
•
A multi-centre, prospective, two-arm, unblinded randomized controlled superiority trial enrolling 478
patients implanted with a first-time ICD or CRT-D from six implanting centres in Denmark
What is the effect of individualised treatment delivered digitally among diabetes patients?
Protocol for the specialist supervised individualised multifactorial treatment of new clinically
diagnosed Type 2 diabetes in General practice (IDA): A Prospective controlled multi-centre open-label
intervention study
1
Stidsen et al. (2017). Study in Progress
Objective
•
A multifactorial intervention study designed to test whether individualised treatment, based on
pathophysiological phenotyping and individualised treatment goals, improves Type 2 diabetes (T2D)
outcomes
Methods
•
A prospective controlled multicentre open-label intervention study, drawing on the longitudinal cohort of
the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) and individualized lifestyle advice
using a complex e-health solution (Liva)
1.
Stidsen et al. Protocol for the specialist supervised individualised multifactorial treatment of new clinically diagnosed Type 2 diabetes in general practice (IDA): A Prospective controlled multicentre
open-label intervention study.
Diabetes and Endocrinology, BMJOpen
– 2017-017493
19
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0020.png
Scientific Research Studies on Liva Underway (2/4)
What is the effect of Liva among overweight and diabetes patients?
Clinical and economic effect of a primary care anchored collaborative eHealth lifestyle coaching
intervention among diabetes patients and overweight patients – A 2-year Randomised Controlled trial
(Liva Study)
Study in Progress (Inclusion period 1
st
of Jan. 2018-1
st
of Feb. 2019)
Objective
•
To assess the effect of Liva intervention among overweight citizens at risk of developing chronic disease
and current diabetes patients motivated to change lifestyle to improve their disease regulation
Methods
•
A two arm multi-centre randomised controlled trial with 1-year intervention and 1-year retention including
340 overweight and diabetic patients (170 in each arm).
Results
•
301 enrolled. First 6 months results among 91 participants show that in the intervention group, 83% are still
active and among overweight patients, a weight loss of avg. 4.8 kg is seen compared to a weight increase
of 0.5 kg among controls.
What is the effect of Liva intervention when anchored in General Practice?
eHealth Lifestyle Coaching among newly diagnosed diabetes patients with integration to GP systems
in a primary care setting – DICTA study
Feasibility study started up August 2019 with 75 patients in 5 GPs
Objective
•
To analyse the effects of a complex intervention using trained dieticians in a general practice setting
combined with the Liva platform and integration to GP systems compared with conventional treatment.
Methods
•
A randomised 2-year intervention trial in a Danish general practice setting including 300 newly diagnosed
diabetes patients.
1.
Brandt CJ, Brandt V, Pedersen M, Glintborg D, Toubro S, Nielsen JB, et al. International journal of family medicine. 2014;2014. PMID: 24860666. doi: 10.1155/2014/245347
20
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0021.png
Scientific Research Studies on Liva Underway (3/4)
What is the effect of digital health promoting initiative in families where the mother had gestational diabetes?
The intervention
•
Face-it is a complex, multi-level health promotion intervention aimed at families, where the mother had
gestational diabetes mellitus (GDM) running from 2018-2022.
•
RCT with 1-year follow-up.
•
Inclusion period from 1
st
of February 2019.
•
The intervention is delivered via two sources; (i) by health visitors with focus on the general wellbeing of
the family, (ii) an interactive digital component (LIVA).
Objectives
•
Reduce the risk of type 2 diabetes (T2DM) and increase quality of life among women with earlier
gestational diabetes and their families
•
Strengthen the collaboration and coordination across healthcare sectors and disciplines to improve
coherence in the care pathway for women with earlier gestational diabetes and their families
?
What is the effect of a digital delivered mediteranian diet intervention in women with previous gestational diabetes?
The intervention
•
The Merit study: A Mediterranean diet intervention delivered through an interactive digital component
(LIVA).
•
Pilot study running from January 2019 and 1 year including 60 women with previous gestational diabetes.
Objectives
•
Investigate the effect of introducing a Mediterranean diet for women with previous gestational diabetes
•
Reduce the risk of type 2 diabetes (T2DM) and increase quality of life among women with earlier
gestational diabetes and their families
21
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0022.png
Scientific Research Studies on Liva Underway (4/4)
Horizon 2020 -
IMPACT DIABETES BUMP 2 BABY
Her må vi se om vi kan finde alle parternes ikoner.
Er der evt en frisk stud med der kan det?
The intervention
•
A low-resource system level intervention for healthy gestational weight gain and improved postnatal
outcomes.
•
A multi-sited 1-year RCT identifying pregnant women at highest risk of developing T2DM running from
2020-2022. 1 year follow up.
•
supports self-management of modifiable lifestyle risk factors through personalised health coaching service
•
Inclusion period from 1
st
of January 2021.
•
It will guide a woman’s journey from pregnancy to birth and beyond covering the infant’s first ‘1000 days’
Objectives
•
800 women, (400 in intervention), will be undertaken across four countries: Ireland, England, Australia and
Spain
•
Focus on scaling up in a cost-effective manner that can be used by a wide audience.
Lev Godt
Ditto her
The intervention
•
A cross-sectoral project that helps people with Diabetes Type 2 maintain good living habits
•
The privat GP, the municipality and local gymnastics- and health associations are coordinating the help
•
Focus on long-term help-settings, social relations, cost-effectiveness and digital educational skills among
heathcare professionals.
Objectives
•
6 municipalities in Region Zealand, Steno Diabetes Centre Zealand. Local Diabetes Associations, DGI,
Absalon
•
Reduce the risk of type 2 diabetes and increase quality of life among people with type 2 diabetes and their
families in a cost-effective manner.
22
Confidential
 SUU, Alm.del - 2019-20 - Bilag 355: Præsentation fra Liva Healthcares foretræde den 5. maj 2020 om teknologiske løsninger til patient rehabilitering og forebyggelse
2186289_0023.png
Contact Liva Healthcare
LIVA Healthcare A/S
Danneskiold-Samsøes Allé 41
DK-1434 Copenhagen K
Denmark
www.livahealthcare.com
Kristoffer From,
Co-founder & CEO
Tel. +45 26 45 43 78
Email: [email protected]
Rune Bech,
Co-founder & Chairman
Tel. +45 20 28 96 66
Email: [email protected]
LIVA Healthcare UK Ltd
12 David Mews
Marylebone, London W1U 6EG
United Kingdom
www.livahealthcare.co.uk
Confidential